Ligand Pharmaceuticals, Inc. (LGND) Misses Q3 EPS by 21c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $288.30 -0.18%
Revenue Growth %: -32.2%
Financial Fact:
Royalties: 15.7M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: -32.2%
Financial Fact:
Royalties: 15.7M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q3 EPS of ($0.20), $0.21 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $5.7 million versus the consensus estimate of $5.9 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
- Oddity Tech Ltd. (ODD) Tops Q2 EPS by 1c
- Cognyte Software (CGNT) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
